Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONCO DVT: Edoxaban Duration for Distal DVT in Cancer
NCT03895502Phase 4Completed
- Start
- May 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of edoxaban in deep vein thrombosis (DVT) (2 arms). Primary endpoint: Symptomatic VTE recurrence event or VTE related death event at 12 months. Started May 2019; status: completed.
02
Drugs
edoxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT03895502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03895502.